TMS Treatment in Turkey: Evidence, Benefits and Who It May Help

It does not require surgery, general anaesthesia or an implanted device, and patients remain awake during treatment. TMS has become an established treatment option particularly for major depressive disorder, including patients who have not improved sufficiently with conventional treatments. Its clinical use also extends to selected psychiatric conditions, while research continues across several areas of neurology.

For patients considering TMS treatment in Turkey, however, access to the technology is only one part of the decision.

The diagnosis, previous treatments, type of TMS, brain target, treatment protocol, number of sessions and medical supervision all influence how TMS should be used. In selected cases, Psychiatry and Neurology may also need to work together around the same treatment plan.

A good TMS programme is therefore not simply about the machine. It is about using the right form of neuromodulation for the right patient, within the right medical pathway.

What Is TMS and How Does It Work?

During TMS treatment, a magnetic coil is positioned against the scalp and delivers carefully controlled magnetic pulses.

These pulses influence the activity of targeted neural networks. The exact brain area and stimulation pattern depend on the condition being treated and the protocol selected.

There is no incision and nothing is implanted into the body. Most patients can leave shortly after each session and continue their normal daily activities.

This combination of targeted brain stimulation and non-invasive treatment is one reason TMS has become increasingly relevant for patients who may already have tried medication, psychotherapy or other conventional treatments.

Is TMS an Evidence-Based Treatment?

Yes — but the strength of evidence differs according to the condition being treated.

The strongest and most established evidence is for major depressive disorder, particularly when previous antidepressant treatment has not provided sufficient improvement.

TMS has now been studied in a large body of randomized clinical trials, systematic reviews and meta-analyses. It is no longer considered simply an experimental treatment for depression.

For appropriately selected patients, it represents a recognised additional treatment option.

That does not mean every patient with depression will benefit, or that every condition advertised alongside TMS has the same level of evidence. Patient selection still matters.

TMS for Treatment-Resistant Depression

Many people considering TMS have already been through several stages of treatment.

They may have tried different antidepressant medications, psychotherapy or combinations of both without achieving sufficient improvement. Others may have experienced medication-related side effects that made treatment difficult to continue.

TMS provides another approach by directly influencing brain networks involved in mood regulation.

For some patients with treatment-resistant depression, this can provide a clinically meaningful additional treatment pathway without surgery or an implanted device.

TMS also does not necessarily replace existing psychiatric treatment. Medication and psychotherapy may continue alongside it depending on the individual treatment plan.

The important question is therefore not simply whether someone has depression. It is whether TMS is an appropriate next step based on the diagnosis, severity of symptoms, previous treatment response and overall clinical history.

TMS for OCD

Obsessive-compulsive disorder is another condition for which TMS has an established clinical application in selected patients.

Deep TMS protocols have been developed specifically for OCD, particularly for people whose symptoms remain significant despite appropriate conventional treatment.

This also illustrates an important point about TMS:

The protocol used for one condition cannot automatically be applied to another.

Different conditions may require different neural targets, stimulation patterns and treatment approaches.

For OCD, TMS should therefore be considered within specialist psychiatric care rather than as a stand-alone procedure.

What About Migraine and Other Neurological Conditions?

TMS is also being used and studied in several areas of neurology.

Research includes migraine, stroke rehabilitation, chronic pain, movement disorders and other neurological conditions.

Some applications are promising, but the evidence is not equally established across all of them. This is particularly important when patients find clinics advertising TMS for long lists of unrelated conditions.

For neurological indications, the first step may need to be a Neurology assessment rather than immediately scheduling TMS.

The neurologist may review the diagnosis, symptoms, medication history, previous imaging and other investigations before deciding whether neuromodulation has an appropriate place in the treatment plan.

In some cases, TMS may be useful. In others, another neurological treatment or further diagnostic evaluation may be more appropriate.

TMS Is Not One Single Treatment

Patients researching TMS often encounter several different terms.

rTMS

Repetitive Transcranial Magnetic Stimulation (rTMS) is the most established form of TMS. Repeated magnetic pulses are delivered according to a specific frequency and treatment protocol.

Deep TMS

Deep TMS (dTMS) uses specialised coil designs intended to stimulate broader neural networks and is used for selected psychiatric indications, including OCD.

Theta Burst Stimulation

Theta Burst Stimulation (TBS) uses a different pattern of magnetic pulses.

Intermittent Theta Burst Stimulation, or iTBS, is particularly interesting because individual treatment sessions can be substantially shorter than conventional rTMS while maintaining clinical effectiveness in appropriately selected patients with depression.

Accelerated TMS

Accelerated TMS approaches deliver multiple stimulation sessions during the same day, allowing certain treatment programmes to be completed within a shorter period.

This can be particularly attractive for international patients.

However, accelerated TMS is not one standardised protocol, and a shorter programme should not automatically be assumed to be medically better.

Travel convenience should be built around the treatment plan — not the other way around.

Why Psychiatry and Neurology May Both Matter

TMS sits at the intersection of psychiatry, neurology and neuroscience.

For depression and OCD, Psychiatry normally leads the clinical assessment and treatment plan.

For patients with neurological symptoms, previous seizures, migraine or other neurological conditions, Neurology may also need to be involved.

Depending on the individual case, the medical team may need to review previous MRI scans, EEG findings, medication history or other investigations.

This does not mean that every patient requires extensive testing. It means that the treatment should be based on a proper understanding of the patient’s condition rather than simply on the availability of a TMS device.

A multidisciplinary approach can help determine:

• whether TMS is appropriate
• which TMS approach should be considered
• whether Psychiatry, Neurology or both should be involved
• how TMS fits alongside existing treatment
• how response should be monitored
• what follow-up will be required afterwards

This becomes even more important when treatment is being planned in another country.

Why Two TMS Programmes Can Be Very Different

Two clinics may both advertise “TMS treatment” while offering very different medical programmes.

The differences may include the type of device, coil design, neural target, stimulation protocol, treatment intensity, number of sessions, medical supervision and how treatment response is monitored.

One programme may involve a structured psychiatric assessment and carefully selected protocol. Another may simply offer a predefined package of sessions.

These are not necessarily equivalent treatments.

This is why comparing TMS purely by the price per session can be misleading.

The more useful questions are:

What are we treating?

Why has this particular TMS protocol been selected?

Who is supervising the treatment medically?

How will we know whether it is working?

How Successful Is TMS?

There is no single percentage that accurately represents the success rate of TMS.

Results vary according to the condition being treated, severity of illness, previous treatment resistance, stimulation protocol, number of sessions and how clinical studies define improvement.

Even within depression, outcomes can differ substantially between patients.

This makes universal claims such as “90% successful” difficult to interpret unless the clinic explains what success means and which type of patients that figure applies to.

For an individual patient, a more useful question is:

What level of improvement can reasonably be expected in someone with my diagnosis and treatment history using the proposed protocol?

That is a medical question rather than a marketing statistic.

How Many TMS Sessions Are Needed?

TMS is usually delivered as a course of repeated sessions rather than as a one-time treatment.

Traditional rTMS programmes for depression commonly involve treatment on multiple days each week over several weeks.

Theta-burst stimulation can make individual sessions much shorter.

Accelerated programmes may provide several sessions within the same day and can potentially reduce the overall length of treatment for selected patients.

For someone travelling to Turkey, this makes planning particularly important.

Before travelling, the complete treatment schedule should be clear:

• number of sessions
• frequency of treatment
• expected length of stay
• when clinical response will be assessed
• whether the programme may change according to response
• whether further or maintenance treatment may later be considered

A shorter treatment session does not necessarily mean a shorter overall treatment programme.

The full medical protocol should be understood before travel arrangements are finalised.

Is TMS Safe?

TMS is generally well tolerated in appropriately selected patients.

Common temporary effects can include headache, scalp discomfort, tingling or facial muscle movement during stimulation.

Seizure is a recognised but rare serious complication.

For this reason, medical screening remains important. Previous seizures, neurological conditions, medications and certain implanted or metallic devices may need to be considered before treatment begins.

TMS does not normally require anaesthesia, and most patients can return to normal activities after treatment.

Its non-invasive nature is one of its major advantages. But non-invasive does not mean that medical assessment and supervision are unnecessary.

What Happens After TMS?

The final TMS session should not automatically mark the end of the patient’s treatment.

Clinical response needs to be assessed and the next stage of care planned.

For patients receiving TMS for depression or OCD, this may involve continued psychiatric follow-up, medication management, psychotherapy or consideration of further or maintenance treatment.

For neurological indications, TMS may be one component of a wider neurological or rehabilitation programme.

This is particularly important when receiving treatment abroad.

Before returning home, patients should understand what follow-up is recommended, whether medication should continue, whether further TMS may be considered and what medical information needs to be shared with their doctors at home.

Continuity should be planned as part of the treatment — not after the patient has already left the country.

Why Consider TMS Treatment in Turkey?

For international patients, Turkey can offer access to modern neuromodulation alongside established Psychiatry, Neurology, diagnostic imaging and other medical specialties.

This can be valuable when a patient’s case requires more than attending a series of TMS sessions.

Some patients may require psychiatric assessment before treatment. Others may benefit from combined Psychiatry and Neurology input.

Previous medical records or imaging may need to be reviewed, or further diagnostic evaluation may be appropriate before the treatment programme is confirmed.

The possibility of coordinating these elements within the same medical pathway can make Turkey an attractive option for patients seeking TMS abroad.

Cost can also be relevant, particularly because TMS often involves multiple sessions. However, patients should compare the complete treatment programme, medical supervision and follow-up rather than looking only at the price of an individual session.

TMS Treatment Through Healing Journey®

Healing Journey® coordinates TMS treatment in Turkey within a wider cross-border medical care pathway.

We begin by reviewing the patient’s diagnosis, previous treatment history and available medical information. Depending on the individual case, we can coordinate evaluation with the appropriate Psychiatry, Neurology or other relevant specialists before the treatment programme is confirmed.

If TMS is appropriate, we identify a suitable provider and coordinate the specialist appointments, treatment protocol and course of sessions around both the medical requirements and the patient’s stay in Turkey.

Where further evaluation is clinically appropriate, neurological assessment, neuroimaging or other investigations can be incorporated into the same care plan.

Our role is not limited to arranging access to the treatment.

We help keep communication between the patient, specialists and treatment providers connected, coordinate changes if the medical plan evolves and support follow-up planning after the TMS course and after the patient returns home.

The technology matters. The medical expertise and care pathway around it matter just as much.

Is TMS Right for You?

TMS has become an important treatment option in modern psychiatry and neuromodulation.

Its strongest evidence is currently in major depressive disorder, including patients who have not responded sufficiently to conventional treatments. It also has established applications in selected patients with OCD, while research continues to develop its role across other psychiatric and neurological conditions.

For the right patient, TMS can provide an important additional treatment option without surgery, general anaesthesia or an implanted device.

The first step is not simply finding a clinic that offers TMS.

It is understanding whether TMS is appropriate for your condition, which approach should be used and what medical expertise should be involved.

Once those questions are answered, the treatment programme can be planned around the patient.